Late on the night of September 23rd, Clifford Carnicom, founder and president of Carnicom Institute, set out by train from Spokane, Washington to attend the 2014 United States Health Freedom Congress in St. Paul Minnesota. He was invited by Diane Miller, JD, Director of Law and Public Policy for the National Health Freedom Coalition (NHFC), and the National Health Freedom Action. These organizations bring together leaders from across the country who are working toward health freedoms and the legislation which can secure these freedoms for people in the United States. Clifford was honored to be invited and to offer a view of his work to people unfamiliar with it. At the same time, he was eager to learn about the work of the other members. I interviewed Clifford upon his return.
I have the responsibility to provide a certain level of detail regarding the planned research and operations for Carnicom Institute during the upcoming year. The primary issue of discussion is the balance between active research and the presentation of that same research to the public. The current situation is that the pace of research during the first half of this year has exceeded the capabilities of the Institute to present and disclose the results of that same research to the public. It is something to be grateful for that such a body of work is in place. The situation is not problematic but the lag is probably on the order of four to six months of work at this time. This dilemma will force certain decisions to be made as to what must be sacrificed with the available resources to achieve the greatest good. The immediate instinct is often to pursue the research needs in the most earnest fashion, as discoveries of some type occur on almost every day of business within this laboratory and associated work. Some of these discoveries are compelling and profound from a scientific standpoint, but the scientific methods demand that such fascinations be held in reserve until they are reliably replicated over a period of time. This is the nature of the work and this has always been the case; however, we must also not assume that infinite time for review and deliberation of our questions and discoveries remain.
A method has been established that shows promise of being effective in removing significant masses of biofilm that encapsulate large quantities of the "cross-domain bacteria" (CDB) as they have been identified and designated by this researcher. This method applies to oral cavities only and it is simple to investigate as to its efficacy. The identification of the CDB has been confirmed by microscopy; one unique feature of this organism is the frequent co-linear arrangement of the bacteria within an encasing filament. The various stages of growth of this life form have been documented extensively on this site, and a progression of development is understood. The term "Morgellons" as popularly used, is insufficient to characterize both the uniqueness of the life form and its ubiquity in the environment. The term "cross-domain bacteria" (i.e., CDB) has been established as being intrinsic to the origin of the life form; attention has been called to the the fact that the scientific nomenclature for this 'new biology' remains woefully inadequate. Any perception that this so-called "condition" is restricted to the human species is false; planetary consequences are before us. Please refer to earlier discussions that elevate the seriousness of this need for increased participation by the scientific and health communities.
Inhibition of growth of the so-called "Morgellons" condition in a cultured environment has been achieved. The primary agents of reduction here, both literally and chemically, are a series of powerful antioxidants. These include ascorbic acid (vitamin C), N-Acetyl Cysteine (NAC) and glutathione. The photograph below shows the result of a culturing process which has been subjected to these antioxidants and their impact upon growth; the effects are rapid and repeatable. The source of this culture is the result of a series of incubation, collection, isolation, extraction and purification processes applied to previous cultures. The original cultures are based upon the use of a variety of human, animal and plant samples, each of which produces identical growth forms. One of many precedents for this work is contained within a previous paper entitled, "Morgellons : A Discovery and A Proposal" (Feb 2010). The basis of the current work is a significant advancement in the development of culture methods.
We now begin the final phase of this paper, and this is to introduce, recall and compile a host of strategies and considerations that may be helpful to mitigate some of the impacts upon health by the Morgellons condition. Some of the work that has been done previously will also be incorporated into and repeated within this section; much of this work remains especially valuable and relevant here as well. It is important to understand that this information is derived from an individual research standpoint only, and that it does not represent any medical advice or diagnosis whatsoever.
We now have a puzzle before all of us. We are likely to have some of the pieces that make up the whole, but we must all work on putting the pieces together. Infrared spectrometry alone cannot do this; additional resources, execution and smart thought will be required. The earlier this puzzle is solved in detail, the better we will all be for it. I can only ask you to join in the crusade. Until that necessary level of understanding is achieved, I will continue to offer my own interpretations below. The discussion will progress through generalized structural interpretations, possible and projected health impacts, and the review of various strategies that may be worthwhile of consideration for mitigation of the anticipated and observed effects of the condition. It will again be emphasized and expressed that no medical advice or diagnosis is to be given here; each individual MUST pursue the counsel and advice of their own chosen health practitioner. The information provided here serves research purposes only.
It has been established, through rather painstaking processes over a period of several years, that primary constituents of the growth form are comprised of both iron and amino acids. The methods to achieve this have been described in detail on previous reports. The essence of impact to health has also been discussed at length, namely, that if these elements are used by the organism for its own growth then those same nutrients are being denied to the human host that supports the invasive growth. Your iron is at the core of your respiration and hence of all energy transfer within your body; proteins are the structural framework that allows your body to exist and grow. The absconding of both iron and amino acids (i.e., proteins) from the human body is by itself of sufficient damage to warrant a full and dedicated allocation of resources to this problem; this has not happened to date. This information has, however, been very useful to develop an entire host of strategies to mitigate this damage and these have been discussed on this site. There remains much to do.
This paper seeks to identify a host of organic compounds that are likely to comprise the core physical structure of biologically produced filaments characteristic of the Morgellons condition. A biological oral filament sample will be analyzed for the presence of candidate organic functional groups using the methods of infrared spectrophotometry. Potential health impacts from these same core structures are examined and compared to the observed , reported and documented symptoms (in part) of this same condition. Potential mitigating strategies, from a research perspective only, are discussed. A body of evidence, accumulated over a period of several years, reveals that the Morgellons condition is likely characterized by a host of serious physiological and metabolic imbalances. These imbalances are caused by the disruption of a variety of major body processes including, as a minimum, the regulation of metabolism by the thyroid, potential liver enlargement, a decrease of oxygen in the circulatory system, the utilization of amino acids important to the body, the oxidation of iron and a potential impact to neural pathways. The impact of this degradation to human health can be concluded to be serious, debilitating and potentially lethal in the cumulative sense; the reports of those who suffer from the condition are in alignment with these conclusions. This paper will summarize the body of work and chronology which leads to this more comprehensive hypothesis.
Under current projections, it will be some months ahead before I will be able to engage fully into the Environmental Filament Project that has been outlined under this site. In the interim, however, an important introduction to what lies ahead can be presented. Carnicom Institute is now able to display a series of scanning electron microphotographs of a typical sample; they will not be discussed in any detail until I am able to begin the study project. Those familiar with my work may be aware of my reluctance to use the term nano-technology in association with any environmental or biological samples examined thus far; this has been due to the lack of any electron microscope images that are derived directly from these same samples. This is no longer the case, and the use of the nano-technology term in association with this material is now fully justified. The samples shown below are identical to those that the United States Environmental Protection Agency has refused to identify or analyze. It has taken close to a decade and a half to acquire these images; appreciation is extended to all parties that have helped to make this information available to the public. Sufficient additional samples have been received, both national and internationally, to support the Institute project plans. This study will begin as the opportunity affords itself and as parallel work that is underway is completed. Light microscope images of the same material are also shown below.
It is now appropriate to disclose the circumstances involving a laboratory report on an airborne filament sample that was paid for in the year of 1999. This report was issued jointly by three separate companies and they shall remain anonymous at this time. It is now appropriate to present this information as the conclusions of the report are undeniably false. Whether or not there was intent to misrepresent the facts of the case is not to be discussed in this paper; the purpose is to disclose information that is relevant to the public interest and welfare. The laboratory was hired and paid significant monies to analyze and identify the very same airborne environmental filament sample that was sent to the United States Environmental Protection Agency (EPA) during this same time period of 1999-2000. The failure of the EPA to identify that sample is adequately documented in this site. This report will chronicle the events that surround this affair.
The Carnicom Institute is embarking on a first of its kind study of the Morgellons condition often referred to as Morgellons Disease. The project will start with a questionnaire process, and this is in progress at this time. Subsequent developments of data collection and/or clinical studies may develop in the future depending upon support and resources.
The Power Hour with Joyce Riley Joyce Riley Interviews Clifford Carnicom February 29, 2012 Download mp3